Bone marrow mobilized with
granulocyte colony-stimulating factor in related allogeneic transplant recipients: A study of 29 patients.
Utilizing
granulocyte colony-stimulating factor to enhance vascular graft endothelialization from circulating blood cells.
The Efficacy and Safety of
Granulocyte Colony-Stimulating Factor for Patients with Stroke.
Several serum markers, including maternal serum APP, alkaline phosphatase,
granulocyte colony-stimulating factor, ferritin, and interleukin-6, were measured in those women and in 111 matched controls.
The company stated that the Phase 3 GENESIS trial is aimed at evaluating the safety, tolerability and efficacy of the combination treatment of BL-8040 and
granulocyte colony-stimulating factor (G-CSF), as compared to the control arm of placebo and G-CSF.
Multicenter prospective nonrandomized controlled clinical trial to prove neuro-therapeutic effects of
granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.
has commenced dosing of patients in a Phase 1 clinical trial of its proprietary long-acting
granulocyte colony-stimulating factor (G-CSF) analog, BBT-015, being developed as a treatment for chemotherapy-related neutropenia in cancer patients and for acute radiation syndrome, the company said.
According to the company, Lonquex is a long-acting recombinant
granulocyte colony-stimulating factor (G-CSF) with the active ingredient lipegfilgrastim - a novel glycoPEGylated (PEG; polyethylene glycol) filgrastim molecule.
The new paradigm in treating patients with hepatitis C infection is to use erythropoietin to treat ribavirin-related anemia in order to maintain ribavirin dosages and enhance quality of life, and to use
granulocyte colony-stimulating factor to treat neutropenia associated with pegylated interferon until early virologic response is achieved, particularly in persons with genotype 1 infection.